ESC 2007: SEARCH-MI validates ICD (implantable cardioverter-defibrillators) guidelines in the "real world" in at-risk heart attack survivors
This article was originally published in Clinica
Executive Summary
Real-world clinical practice data are now available to confirm the value of using implantable cardioverter-defibrillators (ICDs) as a prophylactic therapy in heart attack survivors with weakened hearts, who are at risk of sudden cardiac death (SCD).
You may also be interested in...
ViiV Anticipates 10%-15% Switchover To Long-Term HIV Option Cabenuva
The company is optimistic about a significant portion of eligible patients opting for its newly approved long-acting HIV therapy over daily, oral antiviral therapy.
FDA Sets New Restrictions For Authorized N95 Decontamination Systems
After reviewing real-world data, the US agency says the decontamination systems should only be used for compatible facemasks and should not be used to clean a mask more than four times.
Biden Signs COVID-19 Relief EO To Expand And Accelerate Testing, Fill PPE Shortages
Under an extensive COVID-19 plan and executive order signed on 21 January, the US president explained how he’ll beef up testing and manufacturing of medtech to fight the virus.
Need a specific report? 1000+ reports available
Buy Reports